Universe Pharmaceuticals (UPC) Prepaid Assets (2021 - 2026)

Universe Pharmaceuticals (UPC) posted Prepaid Assets of $41216.0 for Q1 2026, up 3.2% sequentially from $39937.0 in Q3 2025.

Universe Pharmaceuticals (UPC) Prepaid Assets (2021 - 2026) Analysis & Trends

Universe Pharmaceuticals has reported Prepaid Assets for 6 years, with the latest figure at $41216.0 in Q1 2026.

Quarterly Prepaid Assets changed N/A year-over-year to $41216.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41216.0 (changed N/A YoY) and the FY2025 annual result came in at $39937.0, down 100.0% from the prior year.
Prepaid Assets grew to $41216.0 in Q1 2026 per UPC's latest filing, from $39937.0 in the prior quarter.
Over five years, Prepaid Assets peaked at $852.4 million in Q3 2024 and troughed at $39937.0 in Q3 2025.
A 5-year average of $107.2 million and a median of $478705.0 in 2022 frame the typical range for Prepaid Assets.
The sharpest annual moves came in 2024 and 2025: Prepaid Assets jumped 1147163.8% in 2024, then sank 100.0% in 2025.
Over 5 years, Prepaid Assets stood at $1.7 million in 2022, then plunged by 95.69% to $74300.0 in 2023, then surged by 1147163.8% to $852.4 million in 2024, then tumbled by 100.0% to $39937.0 in 2025, then rose by 3.2% to $41216.0 in 2026.
According to Business Quant data, Prepaid Assets over the past three periods registered $41216.0, $39937.0, and $852.4 million for Q1 2026, Q3 2025, and Q3 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Universe Pharmaceuticals	2.93 Mn	-26.11 Mn	-

Download Data